To further determine whether caffeic acid treatment affects the stem cell-like properties of colorectal CSCs in vivo, we assessed the percentage of the CD44+ CD133+ subpopulation of tumor-xenograft-derived cells. The gene discussed is PROM1; the disease is neoplasm.